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SUMMARY 
 
S1. Experimental procedures for preparation of Zn(bix) spheres, encapsulation of 
fluorescent drugs in the Zn(bix) spheres, in vitro release studies and in vitro cytotoxicity 
assays. 
S2. SEM (Scanning Electron Microscope) and TEM (Transmission Electron Microscope) 
images of DOX/Zn(bix) spheres. 
S3. Fluorescence optical microscope images of DOX/Zn(bix), DAU/Zn(bix), CPT/Zn(bix) 
and SN38/Zn(bix) spheres collected at: DOX/Zn(bix) and DAU/Zn(bix): exc= 540 - 552 
nm and em > 590 nm; CPT/Zn(bix): exc= 359 - 371 nm and em > 397 nm;  
SN38/Zn(bix): exc= 450 - 490 nm and em > 515 nm. 
S4. Dynamic light scattering (DLS) measurements of a dispersion of DOX/Zn(bix) spheres 
in PBS at 37 ºC at different times (0, 8 and 24 hours). 
S5. In vitro cytotoxicity assay curves for HL60 cells obtained by plotting the cell viability 
percentage against Zn(bix) and DOX/Zn(bix) concentration 
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S1. Experimental procedures for preparation of Zn(bix) spheres, encapsulation of 
fluorescent drugs in the Zn(bix) spheres, in vitro release studies and in vitro 
cytotoxicity assays 
 
MATERIALS 
 
All reagents were purchased from ALDRICH and used without further purification unless otherwise indicated. 
All HPLC quality solvents used were purchased from ROMIL, and used without further purification. 
The 1,4-bis(imidazol-1-ylmethyl)benzene (bix) was synthesized according to literature procedures P. K. Dhal, 
F. H. Arnold, Macromolecules 1992, 25, 7051.  
 
PREPARATION OF Zn(bix) SPHERES 
 
Zn(bix) spheres were fabricated by addition of an aqueous solution (5 mL) of Zn(NO3)26H2O (150 mg, 0.5 
mmol) to an ethanolic solution (25 mL) of bix ligand (121 mg, 0.5 mmol) under stirring at room temperature. 
Immediately, the precipitation of a white solid was observed. After 1 minute, ethanol (50 mL) was added into 
the reaction mixture to stabilize the spheres. The resulting spheres were then purified by centrifugation and 
washing three times with ethanol. Zn(bix) particles were collected as a white solid or redispersed in ethanol to 
obtain a white colloid. Zn(bix) spheres with different average sizes were prepared using the same synthetic 
methodology and by simply modifying the concentration of both Zn(NO3)26H2O and bix ligand. Anal. (%) 
Calcd. for C14H14O6ZnN6: C, 39.31; H, 3.30; N, 19.65; Found: C, 40.25; H, 3.57; N, 19.52. IR (ATR, cm-1): 2980 
(s), 1618 (s), 1524 (s), 1426 (m), 1332 (s), 1092 (s), 954 (m), 654 (m). 
 
ENCAPSULATION IN Zn(bix) SPHERES 
 
Drug/Zn(bix) spheres were obtained by addition of an aqueous solution (5 mL) of Zn(NO3)26H2O (150 mg, 0.5 
mmol) to an ethanolic solution (25 mL) of Bix (121 mg, 0.5 mmol) containing the drug (DOX, DAU, CPT and 
SN38) (3.3  10-3 M) under vigorous stirring at room temperature. For all drugs, the resulting encapsulated 
metal-organic systems were purified by centrifugation and washed three times with ethanol. The encapsulated 
systems were finally redispersed in ethanol or phosphate buffer to obtain the corresponding colloidal solutions. 
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IN VITRO RELEASE STUDIES  
 
A dialysis bag (cut-off molecular weight: 3500) containing the Drug/Zn(bix) spheres (c ~ 6 mg/mL) dispersed in 
phosphate buffered saline solution (PBS; pH = 7.4) was placed in 100 mL of PBS (pH = 7.4; dialysate) at 37 
ºC under light stirring. Throughout the experimental procedure, the solution inside the dialysis bag was also 
agitated by magnetic stirring. To determine the increase of Drug concentration diffused through the dialysis 
bag, 2 mL of external PBS solution were taken from the dialysate at prefixed times, and each aliquot was 
analyzed by fluorescence spectroscopy. To minimize the effects of Drug decomposition in solution, every four 
hours the external solution of PBS was changed. 
 
CHARACTERIZATION 
 
Scanning electron microscopy (SEM) images were collected on a scanning electron microscope (HITACHI S-
570) at acceleration voltages of 10-15 kV. Aluminium was used as support. Transmission electron microscopy 
(TEM) images were obtained with a JEOL JEM 2010F. The measurements were performed at room 
temperature and a voltage of 200 kV. Optical and fluorescence images were obtained using a Zeiss Axio 
Observer Z-1 inverted optical/fluorescence microscope with motorized XY stage, Hg lamp excitation source, 
AxioCam HRc digital camera and standard filters. Fluorescence emission spectra of Drugs/Zn(bix) were 
measured at exc.= 470 nm in PBS by means of a custom-made spectrofluorimeter, where a Brilliant (Quantel) 
pulsed laser is used as excitation source, and the emitted photons are detected in an Andor ICCD camera 
coupled to a spectrograph.  
 
IN VITRO CYTOTOXICITY ASSAYS 
 
In order to determine the cytotoxic effects of the metal-organic systems, we first seed the acute promyelocytic 
leukemia cell line (HL-60, ATCC No. CCL-240) into 96-well plates in a volume of 100 l with 1 x 104 cells per 
well. Afterwards, the effect of the Zn(bix) and DOX/Zn(bix) spheres in cell viability was evaluated by 
redispersion of the capsules in culture medium to obtain the final concentrations tested (100 M, 10 M, 5 M, 
1 M, 0,5 M, 0,1 M, 0,05 M and 0,01 M) in a volume of 100 l/well, and subsequent addition of these 
solutions to the seed cells for incubation times of 24 h and 48 h at 37ºC. After the incubation times, 20 l of 
MTT solution (EZ4U kit, cell proliferation and cytotoxicity assay, from Biomedica) were added to each well, and 
after 3 hours of reaction, the cell viability was determined by measuring the absorbance at 450 nm using the 
Victor3 multilabel plate reader from PerkinElmer. The cytotoxicity experiments were performed at least three 
times with four repeated incubations per well plate. From the cytotoxicity assays, viability measurements of 
cells at variable dose of spheres were used to calculate the IC50 in order to obtain the concentration of spheres 
that gives a response half way between the minimum and the maximum values of viability. For this goal, the 
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data was analyzed by the software GraphPad Prism 5 to use a nonlinear regression with a pharmacological 
model of dose response stimulation with variable slope. This model assumes that the dose response curve 
has a standard slope, equal to a Hill slope (or slope factor) of 1.0.  
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S2. SEM (Scanning Electron Microscope) and TEM (Transmission Electron 
Microscope) images of DOX/ZnBix spheres. 
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S3. Fluorescence optical microscope images of DOX/Zn(bix), DAU/Zn(bix), 
CPT/Zn(bix) and SN38/Zn(bix) spheres collected at: DOX/Zn(bix) and DAU/Zn(bix): 
exc= 540 - 552 nm and em > 590 nm; CPT/Zn(bix): exc= 359 - 371 nm and em > 
397 nm;  SN38/Zn(bix): exc= 450 - 490 nm and em > 515 nm. 
 
 
DOX/Zn(bix)               DAU/Zn(bix) 
                   
 
CPT/Zn(bix)               SN38/Zn(bix) 
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S4. Dynamic light scattering (DLS) measurements of a dispersion of DOX/Zn(bix) 
spheres in PBS at 37 ºC at different times (0, 8 and 24 hours). 
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S5. In vitro cytotoxicity assay curves after 48 hours for HL60 cells obtained by plotting 
the cell viability percentage against Zn(bix) and DOX/Zn(bix) concentration. 
 
 
 
 
 
IC50 Zn(bix) = 99.9 μM 
IC50 DOX/Zn(bix) = 4.5 μM 
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